Status
Conditions
About
This is a prospective cohort study using gene expression to study patients with infection and sepsis from pneumonia.
Full description
This is a prospective cohort study using single cell transcriptomic profiling and plasma DNA tissue mapping on patients with pneumonia with or without sepsis. The major application of the investigator's study would be the discovery of gene expressions in different leucocytes and plasma DNA associated with each type of organ dysfunction in sepsis. These include cardiovascular, respiratory, hepatic, renal, neurological and haematological dysfunction. This would help prediction, diagnosis and development of therapies to treat sepsis. Leucocyte single cell transcriptome and plasma DNA tissue mapping may addresses the limitations of current evidence in 3 ways: (1) differentiate patients with uncomplicated pneumonia versus pneumonia with associated sepsis, (2) correlation with types and severity of organ dysfunction and (3) identifying molecular phenotypes of sepsis.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
All of the following:
Exclusion criteria
Any of the following:
120 participants in 2 patient groups
Loading...
Central trial contact
Lowell Ling, FCICM; Gavin Joynt, FCICM
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal